Skip to content
GLP Loss
Head to head

NuuVim vs Tru2u

One of these sellers publishes the rate it does not advertise; the other does not sell the medication it prices, and says so in its own terms.

By Hana BrennanPricing & provider data

NuuVim

Editorial

$199.67/mo

The advertised rate covers the first three months only, and the standard semaglutide rate NuuVim publishes in the next column of the same card is $133 a month, billed as one three-month payment rather than monthly. One price applies at every dose, stated on each card, with free shipping and no membership fee.

  • Introductory and standing rates published side by side
  • One price at every dose, stated on every card
  • Two partner pharmacies named with street addresses
  • Free shipping and no membership fee
  • The advertised figure covers only the first three months
  • Billing is one three-month payment, not monthly
  • Marketing repeats the introductory rate, not the standing one
  • Fees paid before cancellation are non-refundable

Pick it for: A rate you can read before you are charged it

Not for: Anyone who needs to pay month by month.

Tru2u

Editorial

$345/mo

Semaglutide is $225 as an injection and $225 as tablets, tirzepatide $345 either way, and a combined injection is $275 — five separate listings, each carrying its own figure. None states a milligram dose, a tablet count or a supply period, and Tru2u states it does not dispense any drug products.

  • Both molecules are offered as an injection and as a tablet
  • Oral and injectable figures are published side by side
  • Free shipping is stated on every order
  • The combined GLP Squared product is priced openly at $275
  • No milligram dose appears on any weight-loss product page
  • No supply period is stated, so $225 covers an unknown amount
  • The clinical partner that sets the final terms is not named
  • Tru2u states it does not dispense the medication it prices

Pick it for: Comparing list prices, if terms elsewhere do not worry you

Not for: Anyone who needs a cost per month.

Our verdict

NuuVim's tirzepatide card carries two columns and its marketing repeats the left one: $133 covers the first three months, and the standing rate sits in the next column. Tru2u's tablet price is genuinely its own, set on the oral listing rather than inherited from the injection — but Tru2u states it does not sell or dispense drug products, routes the consultation to an unnamed third-party partner, and publishes neither a strength nor a tablet count.

What actually separates them

NuuVim and Tru2u state different things about published price. Everything else they publish, they publish the same way.

Tru2u costs $145.33 more than NuuVim — 73% more for the same molecule. Whether that buys anything is what the rest of this page is for.

Over twelve months that is about $2,396 at NuuVim against $4,140 at Tru2u — a difference of $1,744.

 NuuVimTru2u
Published price$199.67/mo$345/mo

What neither of them tells you

A comparison that only reports differences implies everything else is settled. Here it is not.

  • Neither publishes a milligram dose, so neither price can be compared with the other — or with anything else.

Before you choose either

Neither of these sellers publishes a milligram dose, so neither price can be compared with the other or with anything else — which is normal in this category and is exactly the problem. Ask both what dose the monthly price buys, and see the sellers that do publish one before you assume the cheaper sticker is the cheaper product.

Our take is computed from a published rubric that does not read commercial status, and what is known about safety applies to both of them equally.

All head-to-head comparisons · The full injections ranking